Lepik K, Mikhailova N, Kondakova E, et al. Nivolumab for treatment of patients with relapsed/refractory classical Hodgkin’s lymphoma (CHL): clinical and patient-reported outcomes. 24th Congress of EHA, abstract PS1239.
Vergoeding CAR T-celtherapie liso-cel (Breyanzi) bij agressief lymfoom
mei 2024 | Lymfoom